Dolby Laboratories Inc. (DLB) Tops Q3 Views, Issues Solid Outlook
Get Alerts DLB Hot Sheet
Financial Fact:
Cost of products: 17.74M
Today's EPS Names:
VAXX, NMRD, AFIB, More
Join SI Premium – FREE
Dolby Laboratories Inc. (NYSE: DLB) reported Q3 GAAP EPS of $0.38, and non-GAAP EPS of $0.52, versus analyst estimate of $0.27. Revenue for the quarter came in at $223.4 million versus the consensus estimate of $210.23 million.
Dolby Laboratories Inc. sees Q4 2014 GAAP EPS of $0.28-$0.33 and no-GAAP $0.43-$0.48, versus the consensus of $0.34. Dolby Laboratories Inc. sees Q4 2014 revenue of $210-220 million, versus the consensus of $223.1 million.
Dolby Laboratories Inc. sees FY2014 revenue of $945-955 million, versus the consensus of $941.5 million.
For earnings history and earnings-related data on Dolby Laboratories Inc. (DLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
- Applied Industrial Technologies (AIT) Tops Q4 EPS by 25c, Beats on Revenue; Offers FY27 EPS Guidance
- Paysafe Limited (PSFE) Misses Q2 EPS by 43c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share